Top compounds associated with response to ZCCHC4


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.097 0.02
mRNA ZM-447439 GDSC1000 pan-cancer AAC 0.087 0.02
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.18 0.02
mRNA SN-38 GDSC1000 pan-cancer AAC 0.078 0.02
mRNA ML210 CTRPv2 pan-cancer AAC -0.076 0.02
Download CSV